glp-1 receptor agonists and cancer risk in adults with obesity show anti-cancer benefits beyond weight loss GLP1 Receptor Agonists—Effects beyond Obesity

We need to wait and see on that long-term data. Shafipour noted that tablet forms of GLP-1 medications could help people stick to weight loss routines

The effects of protein and supplements on sarcopenia in human clinical studies: how older adults should consume protein and supplements

Furthermore, continuous pipeline advancements point to robust future expansion in this market

The STEP-HFpEF trial randomised 529 patients with obesity (BMI 30 kg/m 2 ), HFpEF (left ventricular ejection fraction [LVEF] 45%) and New York Heart Association (NYHA) Class II symptoms to once-weekly subcutaneous semaglutide 2.4 mg or placebo

doi: 10.1038/ijo.2013.120

The exact mechanisms through which activation of THR improves MASH are still unclear but are known to control fat synthesis, regulate fatty acid oxidation, regulate cholesterol metabolism, improve mitochondrial function, and reduce inflammation and fibrosis